Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Anti-PD1 in HCC
- Status
- COMPLETED
- Phase
- PHASE2
Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant
- Status
- WITHDRAWN
- Phase
- PHASE1
Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
- Status
- SUSPENDED
- Phase
- PHASE2
Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of TRK-950 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fedratinib in Combination With Nivolumab
- Status
- COMPLETED
- Phase
- PHASE2
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
- Status
- RECRUITING
- Phase
- PHASE2
A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy of VTP-300 in Chronic Hepatitis B Infection
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2